CEO Brainard, along with experts, discuss positive final results in the Phase 2 Posoleucel Multi-Virus Prevention Study as presented at the recently held 64th ASH Annual Meeting on an investor webcast to be held on December 14 at 4:30 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALVR: